Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Net Income towards Common Stockholders (2017 - 2025)

Selectis Health's Net Income towards Common Stockholders history spans 14 years, with the latest figure at -$811621.0 for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at -$811621.0 for Q4 2025, down 40.79% from a year ago — trailing twelve months through Dec 2025 was -$1.1 million (up 56.95% YoY), and the annual figure for FY2025 was -$1.1 million, up 56.95%.
  • Net Income towards Common Stockholders for Q4 2025 was -$811621.0 at Selectis Health, down from $744865.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $4.0 million in Q1 2023 to a low of -$3.6 million in Q4 2023.
  • The 5-year median for Net Income towards Common Stockholders is -$674874.5 (2021), against an average of -$586584.3.
  • The sharpest move saw Net Income towards Common Stockholders crashed 1784.11% in 2022, then soared 1656.91% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at -$1.8 million in 2021, then fell by 22.32% to -$2.2 million in 2022, then crashed by 65.5% to -$3.6 million in 2023, then soared by 84.17% to -$576463.0 in 2024, then plummeted by 40.79% to -$811621.0 in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$811621.0, $744865.0, and -$315527.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.